Dr. E shares a case study of one of his patients who has type 2 diabetes, several conditions related to metabolic syndrome, and a recent diagnosis of kidney disease. Discover Dr. E’s treatment strategy and his six pillars of therapy to prevent the progression of CKD.
read more →
Cardiovascular-kidney-metabolic (CKM) syndrome is a condition that happens when heart problems, kidney issues, and metabolic troubles all become intertwined. Learn why people with type 2 diabetes are at higher risk.
read more →
Did you know that kidney disease doesn’t have any symptoms in its early stages? That’s why it’s so important to be proactive in caring for these bean-shaped fluid-filterers. Drs. E+P share the three things you can do to avoid kidney disease, two tests you should have every year, and CKD treatment options that can prevent its progression.
read more →
Dr. E’s patient Harry has an excellent time in range over 90%, and his 30-day CGM report listed an estimated A1c of 6.8%. When Harry’s blood work came back from the lab, his A1c was 4.9%. Why the big discrepancy?
read more →
People with diabetes are at higher risk for certain conditions like chronic kidney disease (CKD). Typically referred to as a “silent disease”, there are often no symptoms in the early stages. That’s why it’s important to talk to your doctor about your risk and get screened to stay on top of your kidney health.
read more →
SGLT2s have been popular in the type 2 diabetes world for years now, due to their cardiovascular benefits, kidney protection, ability to reduce A1c, and influence on weight loss. Dr. Preethika Ekanayake discusses the benefits (and the risks) for use in T1D.
read more →
Dr. Edelman discusses the important role ACE inhibitors and ARBs play in protecting your heart and kidneys.
read more →
We are fortunate to have many medications today to treat type 2 diabetes. Beyond improving glucose levels, some of these medications also have beneficial effects on other conditions that are common in people with type 2, such as heart failure and diabetic kidney disease.
read more →
The FDA recently approved Kerendia, a new medication that addresses the management of certain complications of type 2 diabetes, including chronic kidney disease and cardiovascular disease.
read more →
Our international panel of diabetes experts discussed highlights from the ADA’s Scientific Sessions, and lead a Q&A on some of the most important advances in diabetes.
read more →
